Skip to content

2027 at other companies

UFP Technologies logo
UFP TechnologiesUFPT
Medtronic logo
MedtronicMDT
Abbott logo
AbbottABT
Haemonetics logo
HaemoneticsHAE
ICU Medical logo
ICU MedicalICUI
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$3.04B-27.0%
Enterprise value$4.41B-19.6%
P/E21.4×-32.8×
P/S1.6×-0.7×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths.

The official record: Integer Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integer Holdings's 2027.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integer Holdings's 2027?
Integer Holdings (ITGR) reported 2027 of $60.32M in Q1 2026.
How has Integer Holdings's 2027 changed year-over-year?
Integer Holdings's 2027 decreased by 2.9% year-over-year, from $62.09M to $60.32M.